Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells.
Open Access
- 20 December 1986
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 5 (13), 3461-3466
- https://doi.org/10.1002/j.1460-2075.1986.tb04670.x
Abstract
Both tumorigenic segregant HeLa X human fibroblast hybrids and tumorigenic HeLa (D98/AH‐2) cells can be converted to a non‐tumorigenic state following introduction of a single copy of a fibroblast t(X;11) chromosome. The translocated chromosome contains approximately 95% of the 11 chromosome and the q26‐qter portion of the X chromosome which contains the hypoxanthine guanine phosphoribosyl transferase (HPRT) gene. Introduction of a human X chromosome has no effect on tumorigenic expression. Suppression of tumorigenicity is relieved by selecting cells which have lost the t(X;11) chromosome by growth in medium containing 6‐thioguanine (6‐TG). Further, reintroduction of the t(X;11) chromosome into tumorigenic 6TGR cells again suppresses tumorigenicity. Thus, the introduction of a single copy of a human chromosome 11 is sufficient to completely suppress the tumorigenic phenotype of HeLa cells and is suggestive of the presence of tumor‐suppressor gene(s) on this chromosome.This publication has 19 references indexed in Scilit:
- Suppression of tumorigenicity in somatic cell hybridsCytogenetic and Genome Research, 1986
- DNA polymorphisms indicate loss of heterozygosity for chromosome 11 of D98AH2 cellsCytogenetic and Genome Research, 1986
- A case for human tumor‐suppressor genesBioEssays, 1985
- Retinoblastoma: Clues to Human OncogenesisScience, 1984
- Isolation of a transforming sequence from a human bladder carcinoma cell lineCell, 1982
- Suppression of tumorigenicityCytogenetic and Genome Research, 1982
- Specific chromosome loss associated with the expression of tumorigenicity in human cell hybridsSomatic Cell and Molecular Genetics, 1981
- Characterization of ouabain resistant, hypoxanthine phosphoribosyl transferase deficient human cells and their usefulness as a general method for the production of human cell hybridsCytogenetic and Genome Research, 1980
- Suppression of malignancy in human cellsNature, 1976
- Suppression of Malignancy by Cell FusionNature, 1969